Parvovirus B19 in anemic liver transplant recipients

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 6, 1996, Pages 756-760

  Ndimbie, O Kimka ^a   Frezza, Eldo ^a,e   Jordan, Jeanne A ^a,b   Koch, William ^c   Van Thiel, David H ^d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN M;

ADULT; ANEMIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ERYTHROPOIESIS; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0029859977     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.6.756-760.1996     Document Type: Article

References (22)

1. Andersen, M. J., P. G. Higgins, L. R. Davis, J. S. Williams, S. E. Jones, and I. M. Kidd. 1985. Experimental parvoviral infection in humans. J. Infect. Dis. 152:257-265.
2. Anderson, M. J., E. Lewis, I. M. Kidd, S. M. Hall, and B. J. Cohen. 1984. An outbreak of erythema infectiosum associated with human parvovirus infection. J. Hyg. Camb. 93:85-93.
3. Azzi, A., S. Ciappi, K. Zakrzewska, M. Morfini, G. Mariana, and P. M. Mannucci. 1992. Human parvovirus B19 infection in hemophiliacs first infused with high purity, virally attenuated factor VIII concentrates. Am. J. Hematol. 39:228-230.
4. Bartholomei Corsi, O., A. Azzi, M. Morfini, R. Fanci, and F. P. Rossi. 1988. Human parvovirus infection in hemophiliaes first infused with treated clotting factor concentrates. J. Med. Virol. 25:165-170.
5. Brown, K. E., S. M. Anderson, and N. S. Young. 1993. Erythrocyte P antigen: cellular receptors for B19 parvovirus. Science 262:114-117.
6. Brown, T., A. Anand, L. D. Richie, J. P. Clewley, and T. M. S. Reid. 1984. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii: 1033-1034.
7. Cattral, M. S., A. N. Langnas, R. S. Markin, D. L. Antonson, T. G. Heffron, I. J. Fox, M. F. Sorrell, and B. W. Shaw. 1994. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 20:813-818.
8. Cossart, Y. E., A. M. Field, B. Cant, and D. Widdows. 1975. Parvovirus- like particles in human sera. Lancet i:72-73.
9. Jordan, J. A. 1995. Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am. J. Obstet. Gynecol. 174:37-42.
10. 9a.Jordan, J. A. Personal communication.
11. Jordan, J. A., and M. B. Durso. 1996. Rapid speciation of the 5 most medically relevant candida species using PCR amplification and a microtiter plate-based detection system. Mol. Diagn. 1:1-8.
12. Koch, W. E. 1995. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays. J. Virol. Methods 55:67-82.
13. Langnas, A. N., R. S. Markin, M. S. Cattral, and S. J. Naides. 1995. Parvovirus B19 as a possible causative agent of fulminant liver failure. Hepatology 22:1661-1665.
14. McOmish, F., P. L. Yap, A. Jordan, H. Hart, B. J. Cohen, and P. Simmonds. 1993. J. Clin. Microbiol. 31:323-328.
15. Morbidity and Mortality Weekly Report. 1989. Risks associated with human parvovirus B19 infection. Morbid. Mortal. Weekly Rep. 38:81-97.
16. Mortimer, P. P., N. L. Luban, J. F. Kelleher, and B. J. Cohen. 1983. Transmission of serum parvovirus B19 parvovirus-like virus by clotting-factor concentrates. Lancet ii:482-484.
17. Nour, B., M. Green, M. Michaels, J. Reyes, A. Tzakis, J. C. Gartner, L. Mcloughlin, and T. E. Starzl. 1993. Parvovirus B19 infection in pediatric transplant patients. Transplantation 56:835.
18. Pattison, J. R., Jr., S. E. Jones, J. Hodgson, et al. 1981. Parvovirus infections and hypoplastic crisis in sickle cell anemia. Lancet 1:664-665.
19. Phillips, D. L., and E. B. Keeffe. 1987. Hematologic manifestation of gastrointestinal disease. Hematol. Oncol. Clin. N. Am. 1:207-228.
20. Reid, D; M., T. M. S. Reid, T. Brown, J. A. N. Rennie, and C. J. Eastmond. 1985. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet i:422-425. (Letter.)
21. Winkler, M., F. Schulze, U. Jost, B. Ringe, and R. Pichlmayr. 1993. Anemia associated with FK506 immunosuppression. Lancet 341:1035-1038. (Letter.)
22. Zeldis, J. B., J. L. Dienstag, and R. P. Gale. 1983. Aplastic anemia and non-A, non-B hepatitis. Am. J. Med. 74:64-68.